BioSpace News Archive

Business

2019-20 AAOMS officers, trustees elected

Victor L. Nannini, DDS, FACS, was introduced as the 102nd president of the American Association of Oral and Maxillofacial Surgeons during its Annual Meeting in September in Boston, Mass..

October 30, 2019
·
4 min read
Taipei Exchange Reported by Scientific American as a Key Pillar in Taiwan Biotech Ecosystem

Scientific American has published Taiwan Healthcare & Life Sciences Review, a country-focused report presenting a comprehensive insight on biotech ecosystem of Taiwan.

October 30, 2019
·
2 min read
Biotech Bay

New Study Shows Growing Shortage of U.S. Oncologists Poses Risks to Women’s Health

Analysis Identifies the 10 Major U.S. Cities Most Likely to Suffer a Shortage of Oncologists

October 30, 2019
·
4 min read
Deals

ESSA Pharma Grants Stock Options - Oct. 30, 2019

ESSA Pharma Inc. announced that, pursuant to its stock option plan, it has granted incentive stock options to non – executive members of the Corporation’s board of directors to purchase up to an aggregate of 225,000 common shares in the capital of the Corporation.

October 30, 2019
·
3 min read
Policy

Giant Magellan Telescope Signs Contract for Telescope Structure

Largest contract ever signed by GMTO for final design and construction of massive telescope structure

October 30, 2019
·
7 min read
Deals

TransEnterix Announces Plan for Reverse Stock Split

Company’s action intended to increase the market price of its Common Stock in connection with its previously-announced pursuit of strategic alternatives

October 30, 2019
·
4 min read
Business

Aerie Pharmaceuticals Announces the Appointment of David A. Hollander, M.D., M.B.A., as Chief Research & Development Officer

Aerie Pharmaceuticals, Inc. announced the appointment of David A. Hollander, M.D., M.B.A., as Chief Research & Development Officer, an executive officer position reporting to Vicente Anido, Jr., Ph.D., Aerie’s Chairman and Chief Executive Officer.

October 30, 2019
·
8 min read
Business

Epizyme Announces Positive Pre-NDA Meeting for Tazemetostat for Follicular Lymphoma, Pipeline Updates and Third Quarter 2019 Results

Pre-NDA Meeting Supports Registration Strategy for Tazemetostat for Follicular Lymphoma Patients with and without EZH2 Activating Mutations and Planned NDA Submission in December 2019

October 30, 2019
·
9 min read
Business

LivaNova Reports Third Quarter 2019 Results

LivaNova PLC, a market-leading medical technology and innovation company, reported results for the quarter ended September 30, 2019.

October 30, 2019
·
31 min read
Business

Lannett To Report Fiscal 2020 First-Quarter Financial Results, Host Conference Call On Wednesday, November 6

Lannett Company, Inc. announced that it will report financial results for its fiscal 2020 first quarter on Wednesday, November 6, 2019, after the market closes.

October 30, 2019
·
1 min read